Results 201 to 210 of about 94,588 (272)

Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity. [PDF]

open access: yesBMC Ophthalmol
Minturn R   +8 more
europepmc   +1 more source

Evaluation of Pain in Intravitreal Bevacizumab Injections

Current Eye Research, 2012
To evaluate the correlation between pain associated with intravitreal bevacizumab injection and the location of the injection.The study included 218 eyes of 218 patients, who received an intravitreal bevacizumab injection at our institution. Pain was measured by the Visual Analog Scale (VAS). Additional parameters recorded included age, sex, indication
Elad Moisseiev, Adiel Barak
exaly   +3 more sources

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy

open access: yesOphthalmology and Eye Diseases, 2013
We evaluated the effect of intravitreal bevacizumab (IVB) injection before pars plana vitrectomy (PPV) on intravitreal hemorrhage (VH) during and after vitrectomy for postoperative the first day and the first month in pseudophakic patients with ...
Ersin Oba
exaly   +2 more sources

A Spectrum of Regression Following Intravitreal Bevacizumab in Retinopathy of Prematurity.

American journal of ophthalmology-glaucoma, 2019
PURPOSE To describe an improved understanding of the regression patterns following off-label intravitreal bevacizumab (IVB) treatment for retinopathy of prematurity (ROP). DESIGN Retrospective cohort study.
Tiffany Chen   +5 more
semanticscholar   +1 more source

Intravitreal Bevacizumab for Retinopathy of Prematurity

Journal of Ocular Pharmacology and Therapeutics, 2011
To evaluate the therapeutic effect of a single intravitreal injection of bevacizumab for treatment of threshold retinopathy in retinopathy of prematurity (ROP).The retrospective study consisted of all infants who developed threshold ROP in fundus zone I or zone II and who consecutively received an intravitreal injection of bevacizumab (0.375 mg, 0.03 ...
Björn C, Harder   +3 more
openaire   +2 more sources

PROGRESSIVE RETINAL DETACHMENT IN INFANTS WITH RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB

Retina, 2017
Purpose: Fibrovascular contraction and tractional retinal detachment (TRD) are recognized complications associated with the use of anti–vascular endothelial growth factor agents in vasoproliferative vitreoretinopathies. The authors characterize TRDs that
Y. Yonekawa   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy